AlphaMol Science Ltd. (Shanghai)
2 clinical trials · Sponsor
◉ Watch AlphaMol Science Ltd. (Shanghai)
| Record | Firm | Date |
|---|---|---|
| Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2). (NCT07684560) | AlphaMol Science Ltd. (Shanghai) | 2026-07-01 |
| A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers (NCT07279636) | AlphaMol Science Ltd. (Shanghai) | 2025-07-21 |
Track AlphaMol Science Ltd. (Shanghai) automatically
Every clearance here is in the API, with alerts when new ones post.